OverviewSuggest Edit

It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
HQIrvine, CA, US

Latest Updates

Employees (est.) (Sept 2021)143(-1%)
Cybersecurity ratingCMore

Key People/Management at Ivantis

Dave Van Meter

Dave Van Meter

President, Chief Executive Officer & Director
Randy Alexander

Randy Alexander

Todd Abraham

Todd Abraham

Vice President of Operations
Mike Chodzko

Mike Chodzko

Vice President of Marketing
Ken Galt

Ken Galt

Vice President of Research & Development
Tara Butler

Tara Butler

Show more

Ivantis Office Locations

Ivantis has an office in Irvine
Irvine, CA, US (HQ)
38 Discovery #150
Irvine, CA, US
201 Technology Dr
Show all (2)

Ivantis Financials and Metrics

Summary Metrics

Founding Date


Ivantis total Funding

$120.3 m

Ivantis latest funding size

$25 m

Time since last funding

5 years ago

Ivantis investors

Ivantis's latest funding round in January 2017 was reported to be $25 m. In total, Ivantis has raised $120.3 m
Show all financial metrics

Ivantis Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Ivantis Online and Social Media Presence

Embed Graph

Ivantis News and Updates

Ivantis Announces Settlement of Glaukos Patent Litigation

IRVINE, Calif., Sept. 15, 2021 /PRNewswire/ -- Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, today announced that it has entered into an agreement with Glaukos...

Ivantis Announces FDA Approval for Its Innovative Hydrus® Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)

IRVINE, Calif., Aug. 13, 2018 /PRNewswire/ -- Ivantis, a company dedicated to developing new and innovative solutions for glaucoma, announced today that it received Food and Drug Administration (FDA) approval for the Hydrus® Microstent, a microinvasive glaucoma surgery (MIGS) device used...

Ivantis Frequently Asked Questions

  • When was Ivantis founded?

    Ivantis was founded in 2007.

  • Who are Ivantis key executives?

    Ivantis's key executives are Dave Van Meter, Randy Alexander and Todd Abraham.

  • How many employees does Ivantis have?

    Ivantis has 143 employees.

  • Who are Ivantis competitors?

    Competitors of Ivantis include Otto Bock HealthCare, Permobil and Leica Microsystems.

  • Where is Ivantis headquarters?

    Ivantis headquarters is located at 38 Discovery #150, Irvine.

  • Where are Ivantis offices?

    Ivantis has an office in Irvine.

  • How many offices does Ivantis have?

    Ivantis has 2 offices.